1. P43 Complement C3 in diabetes: hypofibrinolysis, glycation and inhibiting interaction with fibrinogen to reduce cardiovascular risk. (26th October 2016) Authors: King, RJ; Schuett, K; Tiede, C; Jankowski, V; John, V; Trehan, A; Simmons, K; Ponnambalam, S; Fishwick, CWG; McPherson, MJ; Tomlinson, DC; Ajjan, RA Journal: Heart Issue: Volume 102(2016)Supplement 8 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A7.08 Novel agents for blocking the interaction of immune complexes with the activatory FCγRIIIA receptor. (24th February 2016) Authors: Baxter, EW; Robinson, JI; Tomlinson, DC; Foster, RJ; Owen, RL; Win, SJ; Nettleship, JE; Tiede, C; Kankanala, J; Owens, RJ; Fishwick, CWG; McPherson, MJ; Morgan, AW Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗